Immutep is listed on the Australian Stock Exchange (ASX:IMM) and on the NASDAQ Global Market (NASDAQ:IMMP) in the U.S. (ADR's).
We are a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, with operations in Europe, Australia, and the U.S.
We are the global leader in the understanding of and in the development of therapeutics that modulate Lymphocyte Activation Gene-3 (“LAG-3”), a cell surface molecule which plays a vital role in regulating T cells and which was discovered by our Chief Scientific Officer and Chief Medical Officer Dr. Frederic Triebel.
Our objective is to harness and strengthen the power of patients’ immune systems through therapeutic intervention for the benefit of patients’ health. We have one pre-clinical and three clinical LAG-3 product candidates under development, including two antibodies for modulating immune responses in autoimmunity and cancer, through pharmaceutical partnerships, with Novartis and GlaxoSmithKline.
Our lead product candidate is eftilagimod alpha (LAG-3Ig or IMP321), a first-in-class antigen presenting cell (APC) activator currently being investigated in clinical trials as a treatment (in combination with chemotherapy or immune therapy) for breast cancer and melanoma.
Latest Media Releases
17/04/2024 09:10:00
SYDNEY, AUSTRALIA – April 17, 2024 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel…
Latest News
Company News /
by Abbey Phillipps -
2 days ago
18 Apr 2024 - A snapshot of the stocks on the move, featuring Nimy Resources, New Age Exploration and Immutep.
Interviews /
by Manny Anton -
26 days ago
25 Mar 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck …
Company News /
by Abbey Phillipps -
5 months ago
09 Nov 2023 - A snapshot of the stocks on the move, featuring Sunstone Metals (ASX:STM), Immutep (ASX:IMM, NASDAQ:IMMP), European Metals Holdings (ASX:EMH & AIM:EMH) and QX Resourc…
Interviews /
by Paul Sanger -
5 months ago
31 Oct 2023 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress of the company's drug candidates, highlighting promising data from the 2023 ESMO Co…
Company News /
by Abbey Phillipps -
5 months ago
23 Oct 2023 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM; NASDAQ:IMMP), Chimeric Therapeutics (ASX:CHM) and Sayona Mining (ASX:SYA; OTCQB:SYAXF).
Company News /
by Peter Milios -
8 months ago
31 Jul 2023 - Immunotherapy company Immutep has released its Quarterly Activities report, which highlights significant progress in late-stage and registrational trials.
Market Reports /
by Peter Milios -
8 months ago
28 Jul 2023 - Australian retail sales experienced a 0.8% decline last month, as reported by the Australian Bureau of Statistics. This result came as a surprise to markets, which ha…
Company News /
by Peter Milios -
10 months ago
20 Jun 2023 - Immutep Limited (ASX:IMM), a clinical-stage biotechnology company focusing on LAG-3 immunotherapies for cancer and autoimmune diseases, has received a new patent from…
Market Reports /
by Peter Milios -
10 months ago
24 May 2023 - At the closing bell, the S&P/ASX 200 was 0.63 per cent lower at 7,213.80. This drop was primarily influenced by the materials and healthcare sectors.
Market Reports /
by Peter Milios -
10 months ago
24 May 2023 - Swiss banks UBS and Credit Suisse are nearing the completion of their merger, with regulatory approval expected by 31 May.
Interviews /
by Paul Sanger -
11 months ago
19 May 2023 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the significance of recent announcements on the back of a surge in trading volume.
Market Reports /
by Peter Milios -
11 months ago
18 May 2023 - At the closing bell, the S&P/ASX 200 was 0.52 per cent higher at 7,236.80. Nufarm's (ASX:NUF) shares rallied 14.2 per cent to $6.05 after announcing a 7 per cent incr…
Market Reports /
by Peter Milios -
11 months ago
18 May 2023 - According to the Australian Bureau of Statistics, the economy experienced a loss of 4,300 jobs in the previous month, which was contrary to economists' predictions of…